Impact of the functionalization onto structure transformation and gas adsorption of MIL-68(In)

A series of functionalization -NH2, -Br and -NO2 has been performed on MIL-68(In) material in order to improve the porosity features of the pristine material. The functional groups grafted onto the ligand and the molar ratios of the ingredient indicate a profound influence on product formation. With the incremental amount of metal source, product structures undergo the transformation from MIL-68 to MIL-53 or QMOF-2. The situation is different depending on the variation of the ligands. Gas (N2, Ar, H2 and CO2) adsorption-desorption isotherms were systematically investigated to explore the impact of the functionalization on the porous prototypical framework. Comparison of adsorption behaviour of N2 and Ar indicates that the polar molecule exhibits striking interaction to N2 molecule, which has a considerable quadrupole moment. Therefore, as a probe molecule, Ar with no quadrupole moment is more suitable to characterize the surface area with the polar groups. Meanwhile, Ar adsorption result confirms that the negative influence on the surface area stems from the size of the substituting groups. The uptake of H2 and CO2 indicates that the introduction of appropriate polar organic groups can effectively enhance the adsorption enthalpy of relative gases and improve the gas adsorption capacity apparently at low pressure. The introduction of -NO2 is in favour of improving the H2 adsorption capacity, while the grafted -NH2 groups can most effectively enhance the CO2 adsorption capacity.

Biocompatible Fe-Based Micropore Metal-Organic Frameworks as Sustained-Release Anticancer Drug Carriers

Sustained-release preparation is a hot spot in antitumor drug research, where the first task is to select suitable drug carriers. Research has revealed that carboxylic acid iron metal⁻organic frameworks (MOFs), constructed from iron (Fe) ions and terephthalic acid, are nontoxic and biocompatible. Due to the breathing effect, the skeleton of this mesoporous material is flexible and can reversibly adapt its pore size through drug adsorption. Therefore, we chose one kind of Fe-MOF, MIL-53(Fe), as a carrier for the anticancer drug oridonin (Ori). In this work, we report the design and synthesis of MIL-53(Fe) and explore its ability as a transport vehicle to deliver Ori. MIL-53(Fe) is characterized by scanning electron microscopy and X-ray powder diffraction. A loading capacity of 56.25 wt % was measured by high performance liquid chromatography. This carrier was safe and nontoxic (cell viability > 95.27%), depending on the results of 3-(4,5-dimethylthiazol-2-yl)--2,5-diphenyltetrazolium bromide assays, lactate dehydrogenase assays, and Annexin V-fluoresce isothiocyanate/propidium iodide double-staining assays. After loading the drug, the structure of the MIL-53(Fe) was not destroyed, and Ori was amorphous in MIL-53(Fe). Based on an analysis of the Ori release profile, results suggest that it lasts for more than seven days in vitro. The cumulative release rate of Ori at the seventh day was about 82.23% and 91.75% in phosphate buffer saline solution at 37 °C under pH 7.2 and pH 5.5, respectively. HepG2 cells were chosen to study the cytotoxicity of Ori@MIL-53(Fe), and the results show that the anticancer ratio of Ori@MIL-53(Fe) system reaches 90.62%. Thus, MIL-53 can be used as a carrier for anticancer drugs and Ori@MIL-53(Fe) is a promising sustained-release drug delivery system for the cancer therapy.

Comment on “Insight into the reversible structural crystalline-state transformation from MIL-53(Al) to MIL-68(Al)” by A. Perea-Cachero, E. Romero, C. Téllez and J. Coronas, CrystEngComm, 2018, 20, 402

The inadvertently published phase transformation from MIL-53 to MIL-68 is merely a deformation of the MIL-53 structure upon DMF adsorption.